| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-88972-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54669-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-81132SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-13963-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47948-0.1mg | |||
| IHC-Prediluted | NBP2-48101 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-05541-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41288-0.025mg | |||
![Immunocytochemistry/Immunofluorescence: TET1 Antibody [NBP1-88972] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm & nuclear membrane.](http://images.novusbio.com/fullsize/TET1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-88972-img0005.jpg "Immunocytochemistry/Immunofluorescence: TET1 Antibody [NBP1-88972] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm & nuclear membrane.")
![Immunohistochemistry-Paraffin: TET1 Antibody [NBP1-88972] - Staining of human placenta shows moderate nuclear positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/TET1-Antibody-Immunohistochemistry-Paraffin-NBP1-88972-img0009.jpg)
![Immunohistochemistry-Paraffin: TET1 Antibody [NBP1-88972] - Staining of human cerebellum shows moderate nuclear positivity in purkinje cells.](http://images.novusbio.com/fullsize/TET1-Antibody-Immunohistochemistry-Paraffin-NBP1-88972-img0006.jpg)
![Immunohistochemistry-Paraffin: TET1 Antibody [NBP1-88972] - Staining of human cervix, uterine shows moderate nuclear positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/TET1-Antibody-Immunohistochemistry-Paraffin-NBP1-88972-img0007.jpg)
![Immunohistochemistry-Paraffin: TET1 Antibody [NBP1-88972] - Staining of human kidney shows moderate nuclear positivity in cells in tubules.](http://images.novusbio.com/fullsize/TET1-Antibody-Immunohistochemistry-Paraffin-NBP1-88972-img0008.jpg)
![Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Analysis in human cerebral cortex and skeletal muscle tissues using NBP2-54669 antibody. Corresponding NEFL RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/antibody/nbp2-54669_rabbit-polyclonal-nf-l-antibody-immunohistochemistry-paraffin-52202494437..jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Analysis in human cerebral cortex and skeletal muscle tissues using NBP2-54669 antibody. Corresponding NEFL RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: NF-L Antibody [NBP2-54669] - Analysis in control (vector only transfected HEK293T lysate) and NEFL over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).](http://images.novusbio.com/fullsize/NF-L-Antibody-Western-Blot-NBP2-54669-img0006.jpg)
![Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Staining of human cerebral cortex shows strong positivity in neuronal processes.](http://images.novusbio.com/fullsize/antibody/nbp2-54669_rabbit-polyclonal-nf-l-antibody-immunohistochemistry-paraffin-52202494530..jpg)
![Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Staining of human cerebellum shows strong positivity in neuronal processes in molecular layer.](http://images.novusbio.com/fullsize/antibody/nbp2-54669_rabbit-polyclonal-nf-l-antibody-immunohistochemistry-paraffin-52202494628..jpg)
![Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Staining of human lymph node shows no positivity in non-germinal center cells as expected.](http://images.novusbio.com/fullsize/antibody/nbp2-54669_rabbit-polyclonal-nf-l-antibody-immunohistochemistry-paraffin-52202494721..jpg)
![Immunohistochemistry-Paraffin: NF-L Antibody [NBP2-54669] -Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/antibody/nbp2-54669_rabbit-polyclonal-nf-l-antibody-immunohistochemistry-paraffin-52202494818..jpg)
![Western Blot: ER beta/NR3A2 Antibody [NBP2-81132] - Total protein from human Adrenal gland, testis and tonsil was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-ER Beta in blocking buffer and detected with an anti-rabbit HRP secondary antibody using West Pico PLUS chemiluminescence detection reagent.](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-Western-Blot-NBP2-81132-img0001.jpg "Western Blot: ER beta/NR3A2 Antibody [NBP2-81132] - Total protein from human Adrenal gland, testis and tonsil was separated on a 7.5% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-ER Beta in blocking buffer and detected with an anti-rabbit HRP secondary antibody using West Pico PLUS chemiluminescence detection reagent.")
![Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody [NBP2-81132] - ER beta / NR3A2 was detected in paraffin-embedded sections of human breast carcinoma tissue using 1:200 Rabbit Anti-Human ER beta / NR3A2 Antigen Affinity-purified Polyclonal Antibody (Catalog # NBP2-81132) overnight at 4 degrees C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using sodium citrate buffer (pH 6.0). Tissue was staining with DAB and counterstained with hematoxylin.](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-Immunohistochemistry-Paraffin-NBP2-81132-img0002.jpg)
![Western Blot: Monoamine Oxidase B Antibody [NBP1-59569] - Mice were pretreated with 5ECdsAP1 aptamer before amphetamine application; tissue samples collected (n = 4 per group) from the VTA at 90 (60 + 30 min) and 180 (60 + 30 + 90 min) minutes after amphetamine. Protein was obtained for Western blot quantitation of MAO-A level using Actin (lower molecular fragments) as a reference shown in lanes 2-4 (90 min samples) or lane 5-6 (180 min). Total protein (10 ug) was used for all lanes except lanes 7 & 9. The blot was stripped and used for MAO-B. Lane 1: molecular size marker of 10 KD ladder; lane 2: 5ECdsAP1 (4 nmol/kg, icv, 1/2 dose); lanes 3 & 5: saline (2 ul, icv); lanes 4 & 6: 5ECdsAP1 (8 nmol/kg, icv); lanes 7, 8, 9 are controls of naive mice with no aptamer or amphetamine (5, 10 and 20 ug protein). Image collected and cropped by CiteAb from the following publication (//www.jbiomedsci.com/content/23/1/21), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Western-Blot-NBP1-59569-img0007.jpg "Western Blot: Monoamine Oxidase B Antibody [NBP1-59569] - Mice were pretreated with 5ECdsAP1 aptamer before amphetamine application; tissue samples collected (n = 4 per group) from the VTA at 90 (60 + 30 min) and 180 (60 + 30 + 90 min) minutes after amphetamine. Protein was obtained for Western blot quantitation of MAO-A level using Actin (lower molecular fragments) as a reference shown in lanes 2-4 (90 min samples) or lane 5-6 (180 min). Total protein (10 ug) was used for all lanes except lanes 7 & 9. The blot was stripped and used for MAO-B. Lane 1: molecular size marker of 10 KD ladder; lane 2: 5ECdsAP1 (4 nmol/kg, icv, 1/2 dose); lanes 3 & 5: saline (2 ul, icv); lanes 4 & 6: 5ECdsAP1 (8 nmol/kg, icv); lanes 7, 8, 9 are controls of naive mice with no aptamer or amphetamine (5, 10 and 20 ug protein). Image collected and cropped by CiteAb from the following publication (//www.jbiomedsci.com/content/23/1/21), licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: Monoamine Oxidase B Antibody [NBP1-59569] - Human Liver tissue.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Immunohistochemistry-Paraffin-NBP1-59569-img0005.jpg)
![Western Blot: Monoamine Oxidase B Antibody [NBP1-59569] - Human heart.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Western-Blot-NBP1-59569-img0006.jpg)
![Simple Western: Monoamine Oxidase B Antibody [NBP1-59569] - Monoamine Oxidase B Antibodies (NBP1-59569), ProteinSimple Western Blot on Jess Instrument. One microgram of human brain tissue lysate was tested with the antibodies diluted 1:10 or 1:20 times. Image from verified customer review.](http://images.novusbio.com/fullsize/antibody/nbp1-59569_rabbit-polyclonal-monoamine-oxidase-b-antibody-simple-western-2042023113029.jpg)
![Western Blot: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - Western Blot analysis of Human Alpha Synuclein showing detection of alpha-Synuclein protein using Rabbit Anti-alpha-Synuclein Monoclonal Antibody, Clone J18 (NBP3-18266). Lane 1: MW ladder. Lane 2: 0.5 ug human alpha synuclein monomer (SPR-321). Lane 3: 2 ug human alpha synuclein monomer (SPR-321). Lane 4: 0.5 ug human alpha synuclein PFFs (SPR-322). Lane 5: 2 ug human alpha synuclein PFFs (SPR-322). Lane 6: 15 ug human Parkinson's Disease brain lysate.. Block: 5% BSA in TBST. Primary Antibody: Rabbit Anti-alpha-Synuclein Monoclonal Antibody (NBP3-18266) at 1:500 for 2 hours at RT with shaking. Secondary Antibody: Goat anti-mouse IgG:HRP at 1:4000 for 1 hour at RT with shaking. Color Development: Chemiluminescent for HRP (Moss) for 5 min in RT. NBP3-18266 does not detect unphosphorylated alpha synuclein.](http://images.novusbio.com/fullsize/alpha-Synuclein-p-Ser-129-Antibody-J18-Western-Blot-NBP3-18266-img0004.jpg "Western Blot: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - Western Blot analysis of Human Alpha Synuclein showing detection of alpha-Synuclein protein using Rabbit Anti-alpha-Synuclein Monoclonal Antibody, Clone J18 (NBP3-18266). Lane 1: MW ladder. Lane 2: 0.5 ug human alpha synuclein monomer (SPR-321). Lane 3: 2 ug human alpha synuclein monomer (SPR-321). Lane 4: 0.5 ug human alpha synuclein PFFs (SPR-322). Lane 5: 2 ug human alpha synuclein PFFs (SPR-322). Lane 6: 15 ug human Parkinson's Disease brain lysate.. Block: 5% BSA in TBST. Primary Antibody: Rabbit Anti-alpha-Synuclein Monoclonal Antibody (NBP3-18266) at 1:500 for 2 hours at RT with shaking. Secondary Antibody: Goat anti-mouse IgG:HRP at 1:4000 for 1 hour at RT with shaking. Color Development: Chemiluminescent for HRP (Moss) for 5 min in RT. NBP3-18266 does not detect unphosphorylated alpha synuclein.")
![Immunohistochemistry: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - C57/BL6 mice were injected with sonicated recombinant mouse alpha synuclein monomers or fibrils at 8 weeks of age. Mice were unilaterally injected in the dorsal striatum (bregma AP + 0.2 mm, L +/1 2.0 mm, V - 3.0 mm) and sacrificed 30 days post-injection. (A) 1.25 uL mouse alpha synuclein monomers. (B) 2.5 uL mouse alpha synuclein monomers. (C) 2.5 ug alpha synuclein PFFs. (C) 5 ug alpha synuclein PFFs Inset: PBS (negative control). Primary antibody: Anti-alpha-Synuclein (NBP3-18266) at 1:10 000. Secondary antibody: anti-rabbit HRP. Mice injected with PFF displayed alpha synuclein staining in the striatum and cortex and contralateral to the injection site.](http://images.novusbio.com/fullsize/alpha-Synuclein-p-Ser-129-Antibody-J18-Immunohistochemistry-NBP3-18266-img0002.jpg)
![Western Blot: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - Western Blot analysis of Mouse Brain showing detection of alpha-Synuclein protein using Rabbit Anti-alpha-Synuclein Monoclonal Antibody, Clone J18 (NBP3-18266). Lane 1: MW ladder. Lane 2: Mouse brain. Load: 15 ug. Block: 5% BSA in TBST. Primary Antibody: Rabbit Anti-alpha-Synuclein Monoclonal Antibody (NBP3-18266) at 1:500 for 2 hours at RT with shaking. Secondary Antibody: Goat anti-mouse IgG:HRP at 1:4000 for 1 hour at RT with shaking. Color Development: Chemiluminescent for HRP (Moss) for 5 min in RT. Multiple bands due to phosphorylation.](http://images.novusbio.com/fullsize/alpha-Synuclein-p-Ser-129-Antibody-J18-Western-Blot-NBP3-18266-img0005.jpg)
![Immunohistochemistry: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - Immunohistochemistry analysis using Mouse Anti-alpha-Synuclein Monoclonal Antibody, Clone J18 (NBP3-18266). C57/BL6 mice were injected with 5 ug sonicated mouse recombinant alpha synuclein PFFs at 8 weeks of age. Mice were unilaterally injected in the dorsal striatum (bregma AP + 0.2 mm, L +/1 2.0 mm, V - 3.0 mm) and sacrificed 30 days post-injection. (A) contralateral cortex. (B) ipsilateral cortex. (C) contralateral striatum. (D) ipsilateral striatum. Primary Antibody: Mouse Anti-alpha-Synuclein Monoclonal Antibody (NBP3-18266) at 1:10000. Secondary Antibody: anti-rabbit HRP. Courtesy of: Porsolt.](http://images.novusbio.com/fullsize/alpha-Synuclein-p-Ser-129-Antibody-J18-Immunohistochemistry-NBP3-18266-img0001.jpg)
![Dot Blot: alpha-Synuclein [p Ser 129] Antibody (J18) [NBP3-18266] - Dot Blot analysis using Rabbit Anti-alpha-Synuclein Monoclonal Antibody, Clone J18 (NBP3-18266). Tissue: alpha synuclein peptide. Primary Antibody: Rabbit Anti-alpha-Synuclein Monoclonal Antibody (NBP3-18266) at 1:500 for 2 hours at RT with shaking . Secondary Antibody: Goat anti-rabbit IgG:HRP at 1:4000 for 1 hour at RT with shaking . Phospho peptide sequence: AYEMP-pS-EEGYQ. Non-phospho peptide sequence: AYEMPSEEGYQ. This sequence is the same for human, mouse, and rat.](http://images.novusbio.com/fullsize/alpha-Synuclein-p-Ser-129-Antibody-J18-Dot-Blot-NBP3-18266-img0003.jpg)
![Western Blot: alpha Endosulfine Antibody [NBP2-13963] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10Lane 2: Human cell line RT-4Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/alpha-Endosulfine-Antibody-Western-Blot-NBP2-13963-img0003.jpg "Western Blot: alpha Endosulfine Antibody [NBP2-13963] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10Lane 2: Human cell line RT-4Lane 3: Human cell line U-251MG sp")
![Immunocytochemistry/Immunofluorescence: alpha Endosulfine Antibody [NBP2-13963] - Immunofluorescent staining of human cell line PC-3 shows localization to nucleus & nucleoli.](http://images.novusbio.com/fullsize/alpha-Endosulfine-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-13963-img0006.jpg)
![Immunohistochemistry-Paraffin: alpha Endosulfine Antibody [NBP2-13963] - Staining of human esophagus shows moderate cytoplasmic and nuclear positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/alpha-Endosulfine-Antibody-Immunohistochemistry-Paraffin-NBP2-13963-img0005.jpg)
![Western Blot: Brg1 Antibody [NBP2-22234] - Whole cell lysate from 293T (15 and 50 ug), HeLa (50 ug), Jurkat (50 ug), and mouse NIH3T3 (50 ug) cells. Antibody used for WB at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/Brg1-Antibody-Western-Blot-NBP2-22234-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: Brg1 Antibody [NBP2-22234] - Whole cell lysate from 293T (15 and 50 ug), HeLa (50 ug), Jurkat (50 ug), and mouse NIH3T3 (50 ug) cells. Antibody used for WB at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry: Brg1 Antibody [NBP2-22234] - Sample: FFPE section of mouse renal cell carcinoma. Antibody: Affinity purified rabbit anti- BRG1 used at a dilution of 1:1,000 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/Brg1-Antibody-Immunohistochemistry-NBP2-22234-img0014.jpg)
![Immunohistochemistry: Brg1 Antibody [NBP2-22234] - Sample: FFPE section of human colon carcinoma. Antibody: Affinity purified rabbit anti- BRG1 used at a dilution of 1:1,000 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/Brg1-Antibody-Immunohistochemistry-NBP2-22234-img0013.jpg)
![Immunoprecipitation: Brg1 Antibody [NBP2-22234] - Whole cell lysate (1 mg for IP; 20% of IP loaded) from 293T cells. Antibodies: NBP2-22234 used for IP at 6 ug/mg lysate. BRG1 was also immunoprecipitated by rabbit anti-BRG1 antibody NB100-2594. For blotting immunoprecipitated BRG1, NBP2-22234 was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/Brg1-Antibody-Immunoprecipitation-NBP2-22234-img0002.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with Cytokeratin 19 Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0006.jpg "Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with Cytokeratin 19 Antibody (KRT19/799 + KRT19/800)")
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Human Bladder Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Human Cervical Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0002.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Human Endometrial Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Human Ovarian Carcinoma stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0004.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) [NBP2-44829] - Human Pancreas stained with Cytokeratin 19 Monoclonal Antibody (KRT19/799 + KRT19/800)](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-KRT19-799-+-KRT19-800-Immunohistochemistry-Paraffin-NBP2-44829-img0005.jpg)
![Western Blot: MeCP2 Antibody [NBP3-05541] - Western blot analysis of tissue lysates using MeCP2 Antibody at a dilution of 1:1,000 in green: [1] protein standard (red), [2] rat whole brain, [3] nuclear fraction of rat brain, [4] mouse whole brain, [5] nuclear fraction of mouse brain lysate. Strong band at about 75kDa in rat and slightly lower in mouse nuclear enriched fractions corresponds to the MeCP2 protein. The same blot was simultaneously probed with chicken pAB to GAP-43 which detects GAP-43 protein in all preparations with apparent molecular weight of 43kDa.](http://images.novusbio.com/fullsize/MeCP2-Antibody-Western-Blot-NBP3-05541-img0002.jpg "Western Blot: MeCP2 Antibody [NBP3-05541] - Western blot analysis of tissue lysates using MeCP2 Antibody at a dilution of 1:1,000 in green: [1] protein standard (red), [2] rat whole brain, [3] nuclear fraction of rat brain, [4] mouse whole brain, [5] nuclear fraction of mouse brain lysate. Strong band at about 75kDa in rat and slightly lower in mouse nuclear enriched fractions corresponds to the MeCP2 protein. The same blot was simultaneously probed with chicken pAB to GAP-43 which detects GAP-43 protein in all preparations with apparent molecular weight of 43kDa.")
![Immunocytochemistry/Immunofluorescence: MeCP2 Antibody [NBP3-05541] - Immunofluorescent analysis of rat cerebellum section stained with MeCP2 Antibody at a dilution of 1:500 in red and costained with chicken pAb to calbindin at a dilution of 1:2,000, in green. The blue is DAPI staining of nuclear DNA. Following transcardial perfusion of rat with 4% paraformaldehyde, brain was post fixed for 1 hour, cut to 45uM, and free-floating sections were stained with the above antibodies. The MeCP2 antibody specifically labels nuclei of neuronal cells to a variable degree, while calbindin is expressed in the dendrites and perikarya of Purkinje cells in the molecular layer of cerebellum.](http://images.novusbio.com/fullsize/MeCP2-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-05541-img0001.jpg)
![Western Blot: alpha-Synuclein Antibody [NBP2-41288] - Analysis of 1 ng of recombinant human SNCA with SNCA antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/alpha-Synuclein-Antibody-Western-Blot-NBP2-41288-img0004.jpg "Western Blot: alpha-Synuclein Antibody [NBP2-41288] - Analysis of 1 ng of recombinant human SNCA with SNCA antibody at 1 ug/ml.")
![Western Blot: alpha-Synuclein Antibody [NBP2-41288] - Western blot analysis of SNCA in mouse cerebellum tissue lysate with SNCA antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/alpha-Synuclein-Antibody-Western-Blot-NBP2-41288-img0001.jpg)
![Immunohistochemistry: alpha-Synuclein Antibody - BSA Free [NBP2-41288] - Immunohistochemistry of alpha-Synuclein in rat brain tissue with alpha-Synuclein antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41288_rabbit-polyclonal-alpha-synuclein-antibody-2711202419241375.jpg)
![Immunocytochemistry/ Immunofluorescence: alpha-Synuclein Antibody - BSA Free [NBP2-41288] - Immunofluorescence of alpha-Synuclein in rat brain tissue with alpha-Synuclein antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41288_rabbit-polyclonal-alpha-synuclein-antibody-27112024201327.jpg)
![Western Blot: Monoamine Oxidase B Antibody [NB100-2826] - Staining of Mouse Liver lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Western-Blot-NB100-2826-img0002.jpg "Western Blot: Monoamine Oxidase B Antibody [NB100-2826] - Staining of Mouse Liver lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: Monoamine Oxidase B Antibody [NB100-2826] - Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing nuclear and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Immunocytochemistry-Immunofluorescence-NB100-2826-img0003.jpg)
![Flow Cytometry: Monoamine Oxidase B Antibody [NB100-2826] - Flow cytometric analysis of paraformaldehyde fixed HepG2 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (1 ug/mL). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Flow-Cytometry-NB100-2826-img0005.jpg)
![Western Blot: Monoamine Oxidase B Antibody [NB100-2826] - Staining of Human Liver (A) with antibody at 0.1 ug/mL and Testes (B) and Breast Cancer (C) lysate with antibody at 0.3ug/mL (35 ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Monoamine-Oxidase-B-Antibody-Western-Blot-NB100-2826-img0001.jpg)
![Western Blot: Ephrin B2 Antibody [NBP1-49857] - (0.1ug/ml) staining of Rat Lung lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Ephrin-B2-Antibody-Western-Blot-NBP1-49857-img0001.jpg "Western Blot: Ephrin B2 Antibody [NBP1-49857] - (0.1ug/ml) staining of Rat Lung lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunohistochemistry: Ephrin-B2 Antibody [NBP1-49857] - (A) Representative photomicrographs (left panel) and bar graph (right panel) showing AVF venous wall thickness in AVF treated with control or Ephrin-B2/Fc (day 21); *P=0.03 (t-test). n=4. Scale bar, 25um. (B) Line graph showing IVC diameter in mice treated with control or Ephrin-B2/Fc; *P<0.0001 (ANOVA). n=4-5. (C) Bar graphs showing percentage of cells in the AVF positive for proliferation (Ki67) or apoptosis (cleaved caspase-3) (day 21); *P=0.02 (t-test). n=4. Image collected and cropped by CiteAb from the following publication (nature.com/articles/s41598-017-13071-2), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Ephrin-B2-Antibody-Immunohistochemistry-NBP1-49857-img0002.jpg)